K-numberK250957
Device nameDisposable Biopsy Forceps (FB-211D); Disposable Biopsy Forceps (FB-221D); Disposable Biopsy Forceps (FB-231D); Disposable Biopsy Forceps (FB-241D)
ApplicantOlympus Medical Systems Corporation
Product codeEOQ
Device classClass II
Decision dateMay 30, 2025
DecisionSubstantially Equivalent
Regulation874.4680
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Disposable Biopsy Forceps FB-211D, FB-221D, FB-231D, and FB-241D are single-use medical devices designed to collect tissue samples from within the tracheobronchial tree during bronchoscopy procedures. Each model features different distal cup shapes (alligator jaw-step, alligator jaw-step with needle, oval, or oval with needle) to suit varying clinical needs. The forceps are inserted through a bronchoscope channel, advanced to the target lesion, and withdrawn with a tissue sample.

Technological characteristics

The subject device differs from the predicate in three key ways: (1) the insertion portion uses a stainless steel coil covered by a polyethylene sheath, versus the predicate's bare coil; (2) it accommodates larger bronchoscope channel diameters (2.0 mm vs. 1.7 mm) and has a larger insertion portion diameter (1.9 mm vs. 1.5 mm); and (3) it uses gamma sterilization instead of ethylene oxide, with a five-year shelf life versus three years. The cup shapes and working length (1150 mm) are substantially similar to the predicate.

Test standards cited

ISO 10993-1 (biocompatibility evaluation), ISO 11137-1:2006/Amd1:2013 and Amd2:2018 (sterilization validation by radiation), ISO 11137-2:2013 (sterilization dosage establishment), ASTM F1980-21 (accelerated aging and package integrity), ISO 11607-1:2019 and ISO 11607-2:2019 (packaging and sterilization).

Substantial equivalence argument

Although the subject device differs in insertion portion design (sheath-covered coil), compatible endoscope dimensions, sterilization method, and shelf life, Olympus demonstrated through bench testing that these differences do not impact device effectiveness or performance. Side-by-side bench tests showed equivalent insertion, withdrawal, opening/closing, and repeated-use performance. Biocompatibility, sterilization validation, stability testing, and human factors evaluation all confirmed safety. The predicate device (FB-433D) is an established single-use biopsy forceps performing the same tissue collection function via the same mechanism, making the subject devices substantially equivalent despite design refinements.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →